CBR3 and cardiomyopathy: For both CBR3-rs1056892 and CBR1-rs9024 variants, carrying the GG genotype along with receiving low-to-moderate doses of anthracycline increased the risk of cardiomyopathy by 3.6-fold compared to AA and GA genotypes [25].